Abstract:Background Niemann-Pick disease type C (NP-C), derived from mutation of the NPC1 or NPC2 gene, is one of the recessive lysosomal lipid storage disorders that are difficult to diagnose and treat. Since NP-C has been rarely reported in China, we reviewed 7 patients with NP-C. Methods The 7 patients had been diagnosed with NP-C from 2007 to 2010 at our department and their laboratory and clinical data were analyzed. Results The 7 patients, 5 males and 2 females, included 4 patients of late infantile subtype and 3 patients of juvenile subtype, in which patients 2 and 3 were siblings. Their clinical symptoms occurred from 4 to 10 years of age, exhibiting as progressive cognitive and language impairment as well as motor retrogression. Six patients were caught by focal or generalized seizures from 1 to 4 years after the onset of the disease. Vertical supranuclear gaze palsy, dysarthria, dysphagia, internal rotation and adduction of bilateral hands and splenomegaly occurred following the progress of clinical symptoms. Five patients had laughter-cataplexy. MRI showed mild brain atrophy in 6 patients. Reduction of total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol occurred in 6 patients. Sea-blue cells and Niemann-Pick cells were found in bone marrow smears. The activity of acid sphingomyelin enzyme was normal or only slightly lower. Supporting or symptomatic treatment improved common clinical symptoms. Conclusions NP-C is a rare autosomal recessive inherited lysosomal storage disease that affects the intellectual development of children and may lead to dementia, vegetative state or death. Clinical features of this disease include vertical supranuclear gaze palsy, seizures and cataplexy. Laboratory features include abnormal plasma cholesterol level, and sea-blue cells and Niemann-Pick cells in bone marrow smears. The treatments of the disease include supporting or symptomatic administration.

Importance of the biochemical investigations for the functional characterization of a NPC1 variant identified by exome sequencing

Genetic and Clinical Characterization of Niemann-Pick Disease Type C with Homozygous NPC1 gene mutation: Insights from whole exome sequencing and advanced neuroimaging of two familial cases

Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine

Rapid whole-genome sequencing identifies a novel homozygous NPC1 variant associated with Niemann–Pick type C1 disease in a 7-week-old male with cholestasis

Genetic and laboratory diagnostic approach in Niemann Pick disease type C

New Cellular Models for Niemann–Pick Type C Disease

A Genetic Modifier of Niemann-Pick Disease, Type C1

Experience of the NPC Brazil Network with a Comprehensive Program for the Screening and Diagnosis of Niemann-Pick Disease Type C

Alterations in Proteostasis Mechanisms in Niemann–Pick Type C Disease

Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1

SSCP analysis by RT-PCR for the prenatal diagnosis of Niemann-Pick disease type C

Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity

Molecular Characterization of the NPC1L1 Variants Identified from Cholesterol Low Absorbers

A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency

Niemann-Pick Disease Type C: Analysis of 7 Patients

Case Report: Be Aware of “New” Features of Niemann–Pick Disease: Insights From Two Pediatric Cases

Endo-lysosomal dysfunction and neuronal–glial crosstalk in Niemann–Pick type C disease

Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1

Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management

Clinical, biochemical, and genotype‐phenotype correlations of 118 patients with Niemann‐Pick disease Types A/B

Global and Targeted Metabolomics for Revealing Metabolomic Alteration in Niemann-Pick Disease Type C Model Cells